PATENT CLAIM ANALYSIS

Application Number: 15865847
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-02
Patent Classification: ["514", "507000"]

Abstract:
The present invention relates to the treatment of solid tumors in humans such as cancer, especially colorectal cancer (CRC), which involves administering multiple boluses of the diastereomerically pure folate adjuvant [6R]-5,10-methylenetetrahydrofolate in 5-fluorouracil (5-FU) based chemotherapy.

Claim (Index 23):
The method according to  claim 1  whereby no statistically significant progression of said solid tumors is observed.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 86.0
- Lexical Diversity: 1.17949
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15114690', '14372701', '12805287', '14811905', '13002758']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7465030122689732
- 35 USC 102 Novelty (BERT): 0.5394307586081746
- Combined Prediction Score: 0.7257957869028934
- Mean Citation Score: 265.23253
- Max Citation Score: 315.36057
- Similarity Product: 144.86501937005906

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test